aTyr Pharma ATYR Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's accrued expenses?
- aTyr Pharma (ATYR) reported accrued expenses of $7.46M in Q1 2026.
- How has aTyr Pharma's accrued expenses changed year-over-year?
- aTyr Pharma's accrued expenses decreased by 5.1% year-over-year, from $7.86M to $7.46M.
- What is the long-term trend for aTyr Pharma's accrued expenses?
- Over 5 years (2020 to 2025), aTyr Pharma's accrued expenses has grown at a 22.3% compound annual growth rate (CAGR), from $3.57M to $9.79M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.